We are live on ! Find out more
VAM

Vazirani Asset Management Portfolio holdings

AUM $43.4M
1-Year Est. Return 84.05%
This Fund
S&P 500
This Quarter Est. Return
+28.76%
1 Year Est. Return
+84.05%
3 Year Est. Return
+464.6%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.5M
AUM Growth
-$11.5M
Cap. Flow
-$12.8M
Cap. Flow %
-77.61%
Top 10 Hldgs %
100%
Holding
21
New
8
Increased
1
Reduced
1
Closed
11

Top Buys

Rank Stock Value
1
DAY
Dayforce
DAY
+$3.44M
2
EXAS
Exact Sciences
EXAS
+$2.01M
3
CFLT
Confluent
CFLT
+$1.47M
4
NSC icon
Norfolk Southern
NSC
+$723K
5
WBD icon
Warner Bros
WBD
+$701K

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$6.4M
2
COOP
Mr. Cooper
COOP
+$5.27M
3
EA icon
Electronic Arts
EA
+$2.02M
4
SPR
Spirit AeroSystems
SPR
+$1.93M
5
ALE
Allete
ALE
+$1.83M

Sector Composition

Rank Sector Weight
1 Technology 31.99%
2 Industrials 26.29%
3 Healthcare 22.77%
4 Communication Services 16.8%
5 Real Estate 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSC icon
1
Norfolk Southern
NSC
$78.8B
$4.33M 26.29%
15,000
+2,500
+20% +$723K
DAY
2
DELISTED
Dayforce
DAY
$3.46M 20.99%
+50,000
New +$3.44M
EXAS
3
DELISTED
Exact Sciences
EXAS
$2.54M 15.41%
+25,000
New +$2.01M
FYBR
4
DELISTED
Frontier Communications
FYBR
$1.9M 11.55%
50,000
-25,000
-33% -$945K
CFLT
5
DELISTED
Confluent
CFLT
$1.81M 11%
+59,920
New +$1.47M
WBD icon
6
Warner Bros
WBD
$64.6B
$865K 5.25%
+30,000
New +$701K
CDTX
7
DELISTED
Cidara Therapeutics
CDTX
$552K 3.35%
+2,500
New +$404K
FOLD
8
DELISTED
Amicus Therapeutics
FOLD
$356K 2.16%
+25,000
New +$246K
HOUS
9
DELISTED
Anywhere Real Estate
HOUS
$354K 2.15%
+25,000
New +$306K
KZR
10
DELISTED
Kezar Life Sciences
KZR
$305K 1.85%
+48,428
New +$282K
ALE
11
DELISTED
Allete
ALE
– –
-27,500
Closed -$1.83M
CCRN
12
DELISTED
Cross Country Healthcare
CCRN
– –
-10,000
Closed -$142K
COMP icon
13
Compass
COMP
$8.27B
– –
-107,700
Closed -$865K
COOP
14
DELISTED
Mr. Cooper
COOP
– –
-25,000
Closed -$5.27M
EA icon
15
Electronic Arts
EA
$52.4B
– –
-10,000
Closed -$2.02M
HBI
16
DELISTED
Hanesbrands
HBI
– –
-125,000
Closed -$824K
OMC icon
17
Omnicom Group
OMC
$22.7B
– –
-17,200
Closed -$1.4M
PLYM
18
DELISTED
Plymouth Industrial REIT
PLYM
– –
-20,000
Closed -$447K
SPR
19
DELISTED
Spirit AeroSystems
SPR
– –
-50,000
Closed -$1.93M
SRDX
20
DELISTED
Surmodics
SRDX
– –
-10,000
Closed -$299K
VRNA
21
DELISTED
Verona Pharma
VRNA
– –
-60,000
Closed -$6.4M

Similar funds

AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return
GC
Gruss & Co West Palm Beach, Florida $42.8M AUM 49.41% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return

Vazirani Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Vazirani Asset Management held 21 positions worth $16.5M, down 41% from $28M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vazirani Asset Management withdrew a net $12.8M in Q4 2025, closing 11 positions and reducing 1 holding. Its most notable exit was Verona Pharma, an estimated $6.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 0% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Vazirani Asset Management opened a new position in Dayforce worth $3.46M.

  • Vazirani Asset Management's largest Q4 2025 buy was Dayforce: 50,000 shares worth $3.46M.
  • Vazirani Asset Management added most to Norfolk Southern in Q4 2025, an estimated $723K increase.
  • Vazirani Asset Management's biggest Q4 2025 reduction was Frontier Communications, cutting an estimated $945K.
  • Vazirani Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $6.4M.
  • Vazirani Asset Management's ten largest holdings make up 100% of its $16.5M portfolio in Q4 2025.
  • Vazirani Asset Management opened 8 new positions and closed 11 in Q4 2025.
  • Vazirani Asset Management's portfolio value fell 41% quarter-over-quarter to $16.5M.

Based on Vazirani Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.